Abstract
We prepared methyl 2,5-dihydroxycinnamate as a stable analogue of erbstatin, a tyrosine kinase inhibitor. This analogue was about 4 times more stable than erbstatin in calf serum. It inhibited epidermal growth factor receptor-associated tyrosine kinase in vitro with an IC50 of 0.15 μg ml. It also inhibited in situ autophosphorylation of epidermal growth factor receptor in A431 cells. Methyl 2,5-dihydroxycinnamate was shown to delay the S-phase induction by epidermal growth factor in quiescent normal rat kidney cells, without affecting the total amount ofDNA synthesis. The effect of erbstatin on S-phase induction was smaller, possibly because of its shorter life time.
Original language | English |
---|---|
Pages (from-to) | 198-200 |
Number of pages | 3 |
Journal | FEBS Letters |
Volume | 260 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1990 Jan 29 |
Externally published | Yes |
Keywords
- (Normal rat kidney cell)
- Cell cycle
- DNA synthesis
- Epidermal growth factor
- Erbstatin
ASJC Scopus subject areas
- Biophysics
- Structural Biology
- Biochemistry
- Molecular Biology
- Genetics
- Cell Biology